Sep 15, 2021 / 02:15PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Well, great. Good morning, everybody, and thanks for joining us for the next session. Very pleased to have AbbVie with us for the session. Before we get started, I just need to read a quick disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
So pleased to have the full team here from AbbVie with us. I'm going to turn it over to Richard Gonzalez, the CEO, and let him make some opening comments, and then we can jump into Q&A.
Richard A. Gonzalez - AbbVie Inc. - Chairman & CEO
All right. Well, thank you, Matthew. We appreciate being invited to the conference. We're excited to be able to participate. I'll start with just a brief overview of how the AbbVie business is performing and talk about our expectations going forward.
First, what I'd say is I feel very good about how the company is
Abbvie Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers